YUVEZZI Campaign Targets Presbyopia - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

YUVEZZI Campaign Targets Presbyopia

Tenpoint Therapeutic’s new national campaign uses puppet characters to spotlight the everyday frustrations of presbyopia

  • July 13, 2026

  • 2 min

Share

Clinical Scorecard: YUVEZZI Campaign Targets Presbyopia

At a Glance

CategoryDetail
ConditionPresbyopia
Key MechanismsDual-agent ophthalmic solution containing carbachol and brimonidine tartrate.
Target PopulationAdults with age-related blurry near vision, typically beginning around age 45.
Care SettingDirect-to-consumer campaign for prescription eye drops.

Key Highlights

  • 0
  • 1
  • 2
  • 3
  • 4

Guideline-Based Recommendations

Diagnosis

  • Presbyopia typically begins around age 45.

Management

  • YUVEZZI is a once-daily prescription eye drop for treatment.

Monitoring & Follow-up

  • Observe for common side effects such as headache and impaired vision.

Risks

  • Temporary eye pain or irritation upon use.

Patient & Prescribing Data

Adults with age-related blurry near vision.

Available through e-pharmacy partner PHILRx or local retail pharmacies.

Clinical Best Practices

  • 0
  • 1

Related Resources & Content

Original Source(s)

YUVEZZI Campaign Targets Presbyopia

  • July 13, 2026

Related Content

Everest Expands Ophthalmology Portfolio in China

Everest Medicines acquires rights to presbyopia eye drop

  • June 15, 2026

  • 2 min
Presbyopia as a Process: Why New Concepts Take Time

Presbyopia evolves over time; our treatment thinking should too

Equal Pay in Ophthalmology? Not Yet

A decade of AAMC salary data reveals a persistent gender pay gap in academic ophthalmology—and projects it will never close at senior ranks